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Abstract 25 
Developing viral vaccines through the ultraviolet (UV) inactivation of virus is 26 
promising technique since it is straightforward and economically affordable, while the 27 
resulting viruses are capable of eliciting an adequate antiviral immune response. 28 
Nodavirus (NNV) is a devastating virus that mainly affects European sea bass juveniles 29 
and larvae, causing serious economic losses in Mediterranean aquaculture. In this work, 30 
a potential vaccine consisting on UV-inactivated NNV (iNNV) was generated and 31 
administered to healthy juveniles of European sea bass to elucidate whether it triggers 32 
the immune response and improves their survival upon challenge. First, iNNV failed to 33 
replicate in cell cultures and its intraperitoneal administration to sea bass juveniles also 34 
failed to produce fish mortality and induction of the type I interferon (IFN) pathway, 35 
indicating that the NNV was efficiently inactivated. By contrast, iNNV administration 36 
induced significant serum non-specific antimicrobial activity as well as a specific 37 
antiviral activity and immunoglobulin M (IgM) titres against NNV. Interestingly, few 38 
changes were observed at transcriptional level in genes related to either innate or 39 
adaptive immunity, suggesting that iNNV could be modulating the immune response at 40 
protein or functional level. In addition, the iNNV vaccinated group showed improved 41 
survival, reaching a relative survival percentage of 57.9%. Moreover, challenged fish 42 
that had been vaccinated presented increased serum antibacterial, antiviral and IgM 43 
titres, as well as the higher transcription of mhc1a, ifn, isg15 and cd8a genes in brain, 44 
while in the head-kidney the transcription of mhc1a, mhc2b and cd8a was down-45 
regulated and mx, isg15 and tcrb was up-regulated. Although the UV-inactivated 46 
vaccine against NNV showed promising results, more effort should be addressed to 47 
improving this prophylactic method by increasing our understanding of its action 48 
mechanisms, thus enabling the mortality rate of NNV to be further reduced. 49 
Keywords: UV, inactivated vaccine, nodavirus, European sea bass, cell-mediated 50 
cytotoxicity, immune response 51 
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1. Introduction 53 
 For viral vaccine development purposes, viruses can be inactivated by several 54 
chemical or physical methods; formaldehyde, β-propiolactone (BPL) or binary ethylene 55 
imine (BEI) being the most widely used chemicals. However, physical inactivation is 56 
more practical since the resulting vaccines could be considered chemical-free products. 57 
Thus, viral inactivation by irradiation, including ultraviolet (UV), mainly UVC (200-58 
280 nm), offers a promising tool for vaccine development since it is easy, affordable 59 
and fast. UV induces dimer formation between adjacent pyrimidines in RNA, blocking 60 
the RNA molecule as a transcription template, but can also produce significant 61 
alterations in the coat proteins (Delrue et al., 2014). However, although virus 62 
inactivation by UV is obviously feasible, its potential use and efficacy for vaccination is 63 
controversial since it is unclear whether these kinds of vaccine induce proper immunity, 64 
and any protection greatly depends on the virus isolate and the severity of the UV-65 
exposure. Preliminary studies in mammals indicated that eastern equine 66 
encephalomyelitis (EEE) and rabies (CVS) virus inactivated by UV were not suitable 67 
for vaccinating mice since no protection was conferred (LoGrippo, 1958). More 68 
recently, UV-inactivation of the murine leukemic virus (Cas) strain Cas-Br-M was seen 69 
to induce a strong cytotoxic T-lymphocyte (CTL) response in mice, protecting them 70 
against disease and inhibiting viral replication (Sarzotti et al., 1994). Furthermore, UV-71 
inactivated porcine reproductive and respiratory syndrome virus (PRRSV) induces 72 
virus-specific and neutralizing antibody responses (Vanhee et al., 2009). By contrast, 73 
UV-inactivated vaccines consisting of foot and mouth disease virus (FMDV) failed to 74 
induce correct antibody response (Mahdy et al., 2015), while, in the case of influenza A, 75 
the vaccine failed to induce protection or an antibody and CTL response (Furuya et al., 76 
2010). Therefore, although UV is useful for inactivating a virus, its potential use for 77 
vaccine development needs to be cautiously evaluated.  78 
 Aquaculture is a fast and highly growing industry worldwide. For this sector, 79 
diseases triggered by viruses and the lack of effective vaccines against them are 80 
bottleneck factors for its success. Among such viruses, nodavirus (NNV) is the causal 81 
agent of viral encephalopathy and retinopathy (VER), which mainly alters brain and 82 
retina structure and function, causing mortality rates of up to 100 % in more than 50 fish 83 
species (Munday et al., 2002; OIE, 2013). NNV is a non-enveloped bipartite single 84 
stranded RNA virus composed of 2 RNA strands in positive sense, RNA1 coding for 85 
viral RNA-dependent RNA polymerase (RdRp), and RNA2 coding for the capsid 86 
protein (CP), which composes the virus coat by assembling multiple units of the single 87 
protein (Delsert et al., 1997; Munday et al., 2002; Sommerset and Nerland, 2004; Tan et 88 
al., 2001). European sea bass (Dicentrarchus labrax) is a very susceptible species to this 89 
virus which can induce up to 100% mortality, mainly in juveniles and larvae stages 90 
(Breuil et al., 1991), affecting negatively the Mediterranean aquaculture. To date, much 91 
effort has been put into obtaining a deeper knowledge of European sea bass immunity, 92 
cell-mediated cytotoxicity (CMC), antimicrobial peptides (AMPs) and interferon (IFN) 93 
responses having been identified as pivotal mechanisms against NNV (Chaves-Pozo et 94 
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al., 2012; Novel et al., 2013; Scapigliati et al., 2010; Valero et al., 2015a,b,c;Valero et 95 
al., 2016a). Despite the great negative impact of NNV in fish farms, all vaccine types 96 
tested so far have failed to totally eradicate the mortalities elicited by this virus. Thus, 97 
recent studies have reported different types of vaccine against NNV, such as 98 
live/inactivated NNV, virus-like particles (VLPs), DNA or recombinant proteins, all of 99 
which only produced partial protection in fish (Kai and Chi, 2008; Kai et al., 2014; Lin 100 
et al., 2016; Luu et al., 2017; Nishizawa et al., 2012; Núñez-Ortiz et al., 2016; Oh et al., 101 
2013; Sommerset et al., 2003; Valero et al., 2016b; Vimal et al., 2014). Most studies 102 
have focused on inactivated vaccines but always using chemicals such as formalin or 103 
BEI (Kai and Chi, 2008; Kai et al., 2014; Núñez-Ortiz et al., 2016; Pakingking et al., 104 
2010,2011), but no study has addressed the efficacy of UV-inactivated vaccines on 105 
NNV infection. For practical purposes there is only a single commercial vaccine 106 
(ALPHA JECT micro® 1 Noda; PharmaQ), consisting on inactivated NNV, with limited 107 
application to sea bass in some Mediterranean countries but its effectiveness is not 108 
reported yet. 109 
UV inactivation of aquatic virus has been widely evaluated (Lytle and 110 
Sagripanti, 2005). Interestingly, viruses of the family Rhabdoviridae (VHSV) are the 111 
most susceptible to UVC radiation, while viruses of the families Birnaviridae (IPNV) a 112 
Nodaviridae (NNV) are the most resistant (Frerichs et al., 2000; Oye and Espen, 2001). 113 
In fact, while the World Organization for Animal Health (OIE) recommends the use of 114 
10 mJ/cm2 of UV to inactivate most aquatic viruses and bacteria the dosage is increased 115 
to 125-200 mJ/cm2 for IPNV and NNV. Unfortunately, even considering its potential 116 
application, little effort has been directed towards generating and testing UV 117 
inactivation for fish virus vaccines. Only one study has tested a vaccine against 118 
infectious Salmon anaemia virus (ISAV) in Atlantic salmon (Salmo salar) (Rivas-119 
Aravena et al., 2015). In this case, UV-inactivated ISAV was encapsulated in chitosan 120 
and administered orally. Upon challenge, the vaccine elicited a partial relative 121 
protection (RPS) of 39%, which increased to 77% when the vaccine contained a DNA 122 
adjuvant. Interestingly, when the immunity was evaluated, no antibodies were detected 123 
in serum and the expression of immune-related genes suggested that the vaccine is 124 
capable of stimulating the innate immune response through IFN and IFN, but not 125 
cellular immunity, and regulated by the stimulation of interleukin (IL)-10 and tumour 126 
growth factor (TGF)- (Rivas-Aravena et al., 2015). Given the lack of knowledge about 127 
the efficiency of viral UV-inactivated vaccines for fish this work looks at the 128 
inactivation of NNV by UV irradiation and studies the immune response triggered in 129 
healthy European sea bass juveniles by vaccination and challenge with NNV, and the 130 
rates of protection offered.  131 
 132 
2. Material and methods 133 
2.1. Animals  134 
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European sea bass juveniles (Dicentrarchus labrax; 10-12 g body weight) were 135 
bred in the facilities of Instituto Español de Oceanografía in Mazarrón (COM-IEO, 136 
Spain) and transported to the University of Murcia (Spain). Fish were kept in 250 L 137 
running seawater (28‰ salinity) aquaria at 24±2ºC, with a 12 h light:12 h dark 138 
photoperiod and fed daily with 3% biomass of a commercial pellet diet (Skretting). 139 
Before sampling, all specimens were anesthetized with 40 µL/L of clove oil, completely 140 
bled and immediately beheaded and weighed. All animal studies were carried out in 141 
accordance with the Guidelines of the European Union Council (2010/63/UE), the 142 
Bioethical Committee of the University of Murcia (Permit Number: A13150104) and 143 
the Instituto Español de Oceanografía (Permit Number: 2010/02) for the use of 144 
laboratory animals. 145 
2.2. Nodavirus (NNV) stocks 146 
Nodavirus (NNV; strain It/411/96, genotype RGNNV) was propagated in the E-147 
11 cell line. Cells were inoculated with NNV and incubated at 25ºC until the cytopathic 148 
effect (CPE) was extensive. The supernatant was harvested and centrifuged to eliminate 149 
cell debris. Virus stocks were titrated in 96-well plates before use in the experiments 150 
(Reed and Müench, 1938). 151 
2.3. Preparation of vaccine 152 
A previous study demonstrated that UV exposure to 254 nm with a dose of 440 153 
µW/cm2 for 10 min (equivalent to 264 mJ/cm2) resulted in the complete inhibition of 154 
NNV infectivity (Frerichs et al., 2000). Based on this, and to ensure complete NNV 155 
inactivation, 100 µl of a NNV batch of 1010 TCID50/mL were diluted 100-fold with 156 
phosphate buffer (PBS) and exposed to UV-C (254 nm; Bio-Link) with a total dose of 157 
800 mJ/cm2. To verify the NNV infectivity, inactivated NNV (iNNV) was cultured by 2 158 
successive passages on E-11 cultures at 25ºC for 10 days. In addition, cell cultures were 159 
processed for RNA isolation and NNV detection by PCR as described below. 160 
2.4. Fish vaccination 161 
European sea bass fish specimens were randomly divided into 4 aquaria (250 L 162 
each) forming two experimental groups in duplicate. Fish were gently sedated by 20 163 
µL/L of clove oil and vaccinated as follows: one group was intraperitoneally (ip) 164 
injected with 100 µl per fish of PBS (Control) while the other group received a single ip 165 
injection with 107 TCID50/fish (iNNV). After vaccination, fish (n = 6 fish/group and 166 
time) were sampled 1, 15 and 30 days post-vaccination (dpv). Blood was obtained from 167 
the caudal peduncles and serum samples by centrifugation at 10,000 g for 10 min at 4ºC 168 
and immediately stored at −80ºC until use. Head-kidney was removed by dissection, 169 
immediately frozen in TRIzol Reagent (Life Technologies) and stored at −80ºC until 170 
use.  171 
2.5. NNV challenge 172 
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Thirty days after vaccination, the remaining fish (20 per aquaria) received a 173 
single intramuscular injection of 100 µL culture medium containing 106 TCID50/fish of 174 
the same NNV isolate since this route of infection has been proven to be the most 175 
effective (Aranguren et al., 2002). Mortality was recorded daily as the cumulative 176 
mortality and relative percentage of survival (RPS) determined. Samples of serum, brain 177 
and head-kidney (n = 6/group and time) were also taken 2 days post-infection (dpi) and 178 
processed as described above. 179 
2.6. Antimicrobial activities 180 
The presence of both innate and specific humoral factors in the serum of 181 
vaccinated fish specimens was determined. 182 
2.6.1. Bactericidal activity 183 
The bactericidal activity was determined against the pathogenic Photobacterium 184 
damselae subsp. piscicida (Phdp) in order to determine whether the vaccine confers 185 
non-specific antimicrobial protection due to humoral factors such as complement or 186 
AMPs. Thus, Phdp strain PP3 was cultivated as described elsewhere (Machado et al., 187 
2015). Exponentially growing bacteria were resuspended in sterile tryptic soy broth 188 
(TSB; Laboratorios Conda) and adjusted to 106 colony-forming units (cfu)/mL. 189 
Bactericidal activity was then determined in serum samples following the method 190 
previously described (Roszell and Anderson, 1996) but with slight modifications. 191 
Briefly, 20 µL of serum samples were added to duplicate wells of a U-shaped 96-well 192 
plate. To each well, 20 µL of Phdp (106 cfu/mL) were added and the plate incubated for 193 
5 h at 25ºC. Twenty-five µL of 3-(4,5 dimethyl-2-yl)-2,5-diphenyl tetrazolium bromide 194 
(MTT; 1 mg/mL; Sigma-Aldrich) were added and incubated for 10 min at 25ºC. Plates 195 
were centrifuged at 2,000 g for 10 min and the precipitate dissolved in 200 µL of 196 
dimethyl sulfoxide (DMSO; Sigma-Aldrich). Negative controls (maximum bacterial 197 
growth) consisted of replacing the fish serum by TSB, while in blanks the bacteria were 198 
omitted (minimum bacterial growth). The absorbance was measured at 560 nm in a 199 
plate reader. Bactericidal activity is expressed as the percentage of bacteria surviving in 200 
relation to the number of bacteria from the blanks. 201 
2.6.2. Antiviral activity 202 
Antiviral activity in terms of lysis, neutralization and/or inhibition of NNV 203 
replication was assayed against NNV. This was determined by incubating 20 µl of 204 
serum samples with 100 µl of NNV (107 TCID50/mL) for 16 h at 4ºC. Positive controls 205 
consisted of replacing the fish serum by culture medium. After incubation, NNV 206 
infectivity was titrated using E-11 cells in 96-well plates after 10 days as described 207 
above (Reed and Müench, 1938). 208 
2.7. Specific anti-NNV IgM levels 209 
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Serum specific immunoglobulin M (IgM) levels against NNV were analysed 210 
following a previously used protocol (Valero et al., 2016b). Briefly, 100 µL of purified 211 
NNV preparation diluted 1:5 with 50 mM carbonate-bicarbonate buffer pH 9.6 was used 212 
to coat flat-bottomed 96-well plates overnight at 4ºC. After three rinses with PBS-T 213 
(PBS with 0.05% Tween-20), the plates were blocked for 2 h at room temperature with 214 
PBS containing 3% bovine serum albumin, followed by four rinses with PBS-T. Then, 215 
100 µl of 1:100 serum dilutions in PBS-T were incubated for 2 h at room temperature, 216 
followed by five rinses with PBS-T. The plates were then incubated with the optimal 217 
dilutions of mouse anti-sea bass IgM monoclonal antibody (Aquatic Diagnostics Ltd.) 218 
and secondary anti-mouse IgG-HRP (Sigma-Aldrich). The absorbance was read at 450 219 
nm. Negative controls consisted of samples without serum or without coating. Sera 220 
from NNV-infected sea bass were also used as positive control.  221 
2.8. Gene expression  222 
Total RNA was isolated from TRIzol Reagent frozen samples following the 223 
manufacturer's instructions. One microgram of total RNA from E-11 cultures or 224 
individual fish brain or head-kidney samples were treated with DNAse I to remove 225 
genomic DNA, and the first strand of cDNA was synthesized by reverse transcription 226 
using the SuperScript IV Reverse Transcriptase (Thermo Fisher) with random hexamers 227 
(Thermo Fisher). 228 
For NNV detection in E-11 cell cultures, we used conventional PCR with the F2 229 
and R3 primers described elsewhere (Nishizawa et al., 1994). PCR products were 230 
separated in a 1.5% agarose gel (Pronadisa) containing 0.01% of Red Safe® (Life 231 
Technologies) and visualized under UV light in brain or head-kidney. The expression of 232 
the genes coding for (i) type I and II IFN pathway, (ii) antigen recognition, (iii) B cell 233 
markers and immunoglobulins, (iv) T cell markers and (v) cell-mediated cytotoxicity 234 
proteins were analysed by real-time PCR, performed with an ABI PRISM 7500 235 
instrument (Applied Biosystems) using SYBR Green PCR Core Reagents (Applied 236 
Biosystems) as previously described (Valero et al., 2016a). The specific primers used 237 
were designed using the Oligo Perfect software tool (Invitrogen) and are shown in Table 238 
1. Prior to the experiments, the specificity of each primer pair was studied using 239 
positive and negative samples. A melting curve analysis of the amplified products 240 
validated the primers for specificity. Negative controls with no template were always 241 
included in the reactions. For each mRNA sample, gene expression was corrected by the 242 
geometric average of the expression of two endogenous genes [elongation factor 1 alpha 243 
(ef1a) and ribosomal protein L13 alpha (l13a)] in each sample and expressed as 2-ΔCt, 244 
where ΔCt is determined by subtracting the endogenous Ct geometric average value 245 
from the target Ct.  246 
2.9. Statistical analysis 247 
Data were analysed by a t-Student test to establish differences between control 248 
and vaccinated groups at each time point (P≤0.05). Data are represented as the mean ± 249 
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standard error of the mean (SEM). Cumulative mortality was represented for both 250 
groups as mean ± SEM (n = 2 replicates) and analysed by a one-way ANOVA followed 251 
by Tukey's post-hoc analysis. A non-parametric Kruskal–Wallis test, followed by a 252 
multiple comparison test, was used when data did not meet parametric assumptions. All 253 
statistical analyses were conducted using StatGraphics software.  254 
 255 
3. Results 256 
3.1. NNV was effectively inactivated by UV irradiation  257 
 After UV-exposure it was determined whether the iNNV was infective and 258 
could be used as a safe vaccine. Thus, iNNV was cultured on E-11 cell line monolayers 259 
and CPE was absent for two passages as can be seen from the cell monolayer images 260 
(Fig. 1A), where extensive CPE of NNV-infected E-11 cells is also shown (Fig. 1A 261 
inset). PCR analysis of the cultures was also negative for the presence of NNV mRNA 262 
(Fig. 1B). In addition, we evaluated whether iNNV is able to activate the type I IFN 263 
pathway once injected into a healthy fish, as the activation of the type I IFN pathway is 264 
the most prominent hallmark of fish immunity following viral infection (Robertsen, 265 
2006). Thus, we evaluated the expression levels of ifn (data not shown), mx, stat1 and 266 
isg15, none of which was stimulated (Fig. 1C-E). Moreover, no mortalities were 267 
observed during the 30 days following iNNV vaccination. Therefore, our results clearly 268 
demonstrate that UV exposure completely inactivated NNV. Furthermore, the iNNV 269 
was not infective and was seen to be safe.  270 
3.2. iNNV vaccination increases both innate and adaptive humoral immunity 271 
 When the presence of both non-specific and specific (for NNV) soluble serum 272 
factors after iNNV vaccination was analysed, the results showed that the iNNV vaccine 273 
significantly increased the innate bactericidal activity in serum at 30 dpv but decreased 274 
the same at 1 dpv (Fig. 2A). Furthermore, the serum antiviral activity increased, as 275 
indicated by the decrease in NNV titres at all the assayed times, reaching significance at 276 
15 and 30 dpv, respectively, compared with the control group (Fig. 2B), suggesting the 277 
presence of neutralizing antibodies. Thus, ELISA determination of specific anti-NNV 278 
IgM sera titres resulted in increased IgM levels that reached significance after 30 dpv 279 
compared with controls and unvaccinated fish (Fig. 2C).  280 
3.2. iNNV down-regulates the transcription of immune-related genes 281 
Few effects and little down-regulation of the genes studied were observed in the 282 
head-kidney (Fig. 3). Firstly, mhc1a and mhc2b genes, both related to antigen 283 
presentation, were down-regulated at 15 and 30 dpv, respectively (Fig. 3A,B). 284 
Moreover, the transcript levels in head-kidney of ighm and cd8a were down-regulated 285 
from 15 dpv onwards (Fig. 3C,G) while ight, tcrb, cd4, prf, gzma and ifng transcription 286 
levels kept steady after vaccination (Fig. 3D,E,F,H,I,J).  287 
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3.3. iNNV improves fish survival by increasing immunity after challenge 288 
 Fish were challenged at 30 dpv (Fig. 4) and the mortalities recorded. In the 289 
control group, fish deaths were recorded from day 5 until day 18, reaching a 20.8% 290 
survival rate (Fig. 4) and showing typical disease symptoms (data not shown), while in 291 
the iNNV vaccinated group deaths were recorded from 2 to 13 dpi (Fig. 4) while the 292 
survival rate rose to 66.7%. This means that the iNNV elicited a RPS (relative 293 
percentage of survival) of 57.9%.  294 
At functional level, 2 days after challenge, increased levels of antibacterial 295 
activity were observed in serum from iNNV vaccinated fish compared with controls 296 
(Fig. 5A). The specific antiviral activity against NNV was enhanced (as determined by a 297 
30.8-fold decrease in the virus titre) (Fig. 5B). Similarly, the specific anti-NNV IgM 298 
levels (Fig. 5C) increased in the serum of iNNV vaccinated fish upon NNV infection. 299 
The gene expression levels of mhc1a, ifn, isg15 and cd8a in the brain of iNNV 300 
vaccinated and challenged fish increased, whereas mhc2b, mx, stat1, ighm, ight, tcrb, 301 
cd4, prf, gzma and ifng gene expression levels remained unchanged (Fig. 6A). However, 302 
in the head-kidney, the expression of mx, isg15 and tcrb genes was up-regulated in 303 
iNNV vaccinated and challenged sea bass specimens, while mhc1a, mhc2b and cd8a 304 
was down-regulated (Fig. 6B). No alterations in the expression of ifn, stat1, ighm, ight, 305 
cd4, prf, gzma and ifng genes was observed in the head-kidney. 306 
 307 
4. Discussion 308 
 The generation of successful vaccines could represent the best solution to the 309 
economic losses produced by NNV in aquaculture. Thus, several types of vaccines 310 
against NNV have been tested (Kai and Chi, 2008; Kai et al., 2014; Lin et al., 2016; 311 
Luu et al., 2017; Nishizawa et al., 2012; Núñez-Ortiz et al., 2016; Oh et al., 2013; 312 
Sommerset et al., 2003; Valero et al., 2016b; Vimal et al., 2014), their origins, based on 313 
chemical or genetic modification, has led to certain public rejection of the same. In a 314 
society increasingly inclined to consume natural food, new approaches are clearly 315 
needed to overcome these concerns in the sector, which produces more than 50% of the 316 
fish destined for human consumption (FAO, 2016). Taking this into account, we 317 
generated and tested for the first time a vaccine consisting of NNV inactivated by means 318 
of UV radiation administrated without any adjuvant guarantying a chemical-free 319 
protocol of immunization.  320 
The first observation was that the inactivation of NNV by UV was complete 321 
since inactivated virus failed to produce CPE in cell cultures or the induction at 322 
transcriptional levels of type I IFN and mortality was zero. NNV was inactivated by an 323 
irradiation dose of 800 mJ/cm2, which was much higher than the dose suggested by the 324 
OIE, 125-200 mJ/cm2.  Our aim was to ensure complete NNV inactivation so that, once 325 
delivered to cultured live fish the virus would not escape and be disseminated in the 326 
wild. A previous study demonstrated that NNV exposure to 211 mJ/cm2 was insufficient 327 
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for this purpose and only the dosage of 264 mJ/cm2 (440 µW/cm2 for 10 min) was 328 
effective (Frerichs et al., 2000). The IFN response is used as the most important 329 
hallmark of virus infection (Robertsen, 2006). In the case of sea bass infected with 330 
NNV, several genes of the I IFN pathway type were up-regulated including ifn, mx, 331 
stat1, isg15, pkr (Carballo et al., 2016; Poisa-Beiro et al., 2008; Scapigliati et al., 2010; 332 
Valero et al., 2015c). Our results show no alterations in the transcription of ifn, mx, 333 
stat1 and isg15, confirming the lack of NNV replication in sea bass cells. In fact, this is 334 
in agreement with other formalin-inactivated ISAV vaccine that failed to induce the 335 
transcription of both type-I and-II IFN related genes (Lauscher et al., 2011). These 336 
findings go against those concerning other non-replicative viral vaccines. For example, 337 
vaccination with BEI-inactivated NNV upregulated mx gene in groupers (Epinephelus 338 
coioides) (Kai et al., 2014) even this was completely inactivated. Interestingly, GB cells 339 
incubated with the same vaccine failed to produce Mx protein, whereas incubation with 340 
NNV isolated RNA did so. Thus, it seems that UV-inactivation results in whole and 341 
completely inactivated virus, but not in the case of chemically-inactivated vaccines, 342 
leading to a complete abrogation of the IFN pathway suggesting that contact with the 343 
viral RNA in its replicative form is necessary to stimulate this pathway. Moreover, the 344 
data showed that iNNV elicited both innate and acquired immune responses but at low 345 
levels. Thus, at humoral level, a substantial increase in innate antimicrobial activities 346 
and specific NNV-IgM serum levels was recorded 30 dpv, with the exception of the 347 
serum antiviral function, which increased from 15 dpv onwards. Both bactericidal and 348 
antiviral activities demonstrate the existence of unspecific factors that were induced by 349 
the iNNV vaccine, probably complement, AMPs or even natural IgM. Similarly, NNV 350 
infection has been demonstrated to increase bactericidal and/or alternative complement 351 
activities in European sea bass (Mauri et al., 2011; Valero et al., 2015b), while some 352 
AMPs have also shown direct lytic/agglutinating activity against NNV in vitro (Chia et 353 
al., 2010). Unfortunately, such observations have never been described after the 354 
vaccination of fish with NNV vaccines. In addition, ELISA demonstrated that serum 355 
IgM specific to NNV had increased by 30 dpv, which could also have contributed to the 356 
anti-viral activity by activating the classical complement system, agglutinating or 357 
neutralizing infective NNV viral particles. Furthermore, anti NNV-IgM production and 358 
the antiviral function observed after iNNV vaccination suggest that the alterations 359 
produced by UV affected viral replication but not the capsid conformation or epitopes 360 
needed to induce the generation of neutralizing specific antibodies, as happens with 361 
heat-denaturalized NNV vaccines, since the NNV structure of the capsid protein, or at 362 
least the major epitopes, are thought to be heat-sensitive (Gye et al., 2018). All these 363 
data taken together demonstrate that iNNV vaccine increased both innate and specific 364 
humoral immunity against NNV and the search for these factors would help to 365 
understand the vaccination process and efficacy.  366 
At transcriptional level, most of the immune-related genes related to humoral 367 
and cellular immunity in head-kidney were down-regulated or remained unaltered after 368 
iNNV vaccination. Thus, apart from the absence of any up-regulation of IFN related 369 
genes, the transcription levels of genes involved in antigen recognition (mhc1a and 370 
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mhc2b) and participating in T and B cell responses (cd8a and ighm, respectively) 371 
decreased at different time points post-vaccination, while those related to CMC and type 372 
II IFN were unaltered. These could indicate that cells presenting iNNV antigen and T 373 
and B cells are trafficked from the haematopoietic tissue to other tissues, as occurs upon 374 
bacterial infection (Chaves-Pozo et al., 2005), a hypothesis that merits further 375 
investigation. Similarly, inactivation of ISAV resulted in the limited or no activation of 376 
salmon immunity at gene level of transcripts related to IFN, MHC, B and T cells, while 377 
specific antibodies were or were not generated with the formalin- or the UV-inactivated 378 
vaccines, respectively (Lauscher et al., 2011; Rivas-Aravena et al., 2015). When the 379 
European sea bass juveniles were challenged after iNNV vaccination, survival was 380 
significantly higher at the end of the challenge.   381 
Our data reflect a noticeable degree of protection from the disease (RPS of 382 
57.9%). Although this RPS is not optimal it is comparable to that obtained in other 383 
studies using NNV-inactivated particles, VLPs or even DNA vaccines (Kai and Chi, 384 
2008; Núñez-Ortiz et al., 2016; Thyéry et al., 2006; Valero et al., 2016b; Vimal et al., 385 
2014). Interestingly, upon vaccination and challenge, bactericidal, antiviral and NNV 386 
specific IgM serum levels were further improved compared to unchallenged specimens, 387 
suggesting an immune response consisting of both innate and specific responses. In 388 
addition, upon NNV challenge of iNNV vaccinated fish, apart from the up-regulation of 389 
some type I IFN genes (ifn, mx and/or isg15) in brain and head-kidney, antigen 390 
presentation and cd8a genes were up-regulated in the brain and down-regulated in the 391 
head-kidney, which is in sharp contrast to what happened in salmon vaccinated and 392 
challenged with ISAV (Lauscher et al., 2011; Rivas-Aravena et al., 2015). This could be 393 
responsible for i) a lower viral load in the central nervous tissue due to a more rapid 394 
immune response that lead to a low level of disease symptoms and increased survival; 395 
and ii) cell trafficking from head-kidney to the brain tissue of antigen presenting cells 396 
and CTLs. This suggests that T cytotoxic lymphocytes are recruited from the head-397 
kidney to the brain, where the local CMC is activated. However, the transcription of 398 
important genes related to CMC such as perforin, granzyme A or the type II IFN (IFN) 399 
was not up-regulated in brain or head-kidney. This suggests that CTLs are recruited to 400 
the brain, although they are not able to kill NNV-infected cells as their specific 401 
mechanism is in some way impaired, an observation that has been already been 402 
documented in the case of sea bass leucocytes in vitro and which seems to be the reason 403 
for the high susceptibility of sea bass compared with other fish species (Chaves-Pozo et 404 
al., 2017). The up-regulation of cd8a and mhc1a in the brain suggests an enhancement 405 
of the brain’s potential to process the virus and recruit CTLs in vaccinated fish 406 
compared to non-vaccinated fish. These observations support the hypothesis of the 407 
CMC, either innate or adaptive, being one of the most relevant immune responses 408 
against NNV. Thus, the transcription of CMC-related genes is increased upon NNV 409 
challenge (Chang et al., 2011; Valero et al., 2018) or vaccination (Kai et al., 2014; 410 
Valero et al., 2016b). Interestingly and in agreement with our data, specific CMC 411 
activity has been described as acting in an MHC-I restricted form and is stimulated 412 
upon reinfection in groupers (Chang et al., 2011). This would explain why mhc1a and 413 
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cd8a gene expression was up-regulated in vaccinated fish upon challenge and not upon 414 
vaccination. Although there are no other studies in fish relating UV-inactivated vaccines 415 
with CMC function, UV-inactivated Cas virus has been seen to stimulate T-cell 416 
responses in mice (Sarzotti et al., 1994), as seems to be the case in European sea bass. 417 
Thus, this work reports the safety of UV as a viable method for developing inactivated 418 
vaccines for fish.  419 
In conclusion, the UV-inactivated vaccine developed against NNV, stimulated 420 
the anti-NNV function, specific antibodies and disease protection when administered 421 
intraperitoneally to healthy European sea bass juveniles, with little changes in the 422 
transcription of important immune-related genes. Interestingly, upon NNV challenge, 423 
iNNV vaccination of fish further increased antiviral activity and up-regulated the 424 
transcription of type I IFN-related genes and CTL marker accompanied by an increase 425 
in NNV-specific IgM levels in serum, resulting in an improvement of fish survival rates. 426 
Further studies on the immunity primed by UV-inactivated viral vaccines would help to 427 
improve their efficacy in fish and against NNV in particular.  428 
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 622 
Figure legends 623 
Figure 1: NNV was completely inactivated by UV exposure (iNNV). A) iNNV was 624 
cultured for 2 consecutive passages on E-11 cell cultures and observed under a phase 625 
contrast microscope. Inset corresponds to the positive control incubated with NNV. 626 
Bars correspond to 100 µm. B) PCR detection of NNV after the first and second 627 
passage of iNNV on E-11 cell cultures. NT, no template; C+, NNV positive culture. C-628 
E) Expression of mx, stat1 and isg15 genes in the head-kidney of European sea bass 629 
specimens 1, 15 and 30 days after intraperitoneal injection (dpv) with PBS (Control) or 630 
UV-inactivated vaccine (iNNV). Data represent the mean ± SEM (n = 6/group and 631 
time). 632 
Figure 2: iNNV vaccine induces both innate and specific humoral immunity. 633 
Bactericidal activity (A), antiviral activity against NNV (B) and specific anti-NNV IgM 634 
levels (C) in the serum of European sea bass specimens 1, 15 and 30 days after 635 
intraperitoneal injection with PBS (Control) or UV-inactivated vaccine (iNNV). Data 636 
represent the mean ± standard error of the mean (SEM; n = 6/group and time). Asterisks 637 
represent statistical differences between control and iNNV groups according to the t-638 
Student test (P<0.05). 639 
Figure 3: iNNV vaccination produces little changes at transcriptional level. Expression 640 
of immune-related genes in the head-kidney of European sea bass specimens 1, 15 and 641 
30 days after intraperitoneal injection (dpv) with PBS (Control) or UV-inactivated 642 
vaccine (iNNV). Data represent the mean ± SEM (n = 6/group and time). Asterisks 643 
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represent statistical differences between control and iNNV groups according to the t-644 
Student test (P<0.05). ND, not detected. 645 
Figure 4: Vaccine iNNV produces partial protection. Cumulative mortality in 646 
intraperitoneally vaccinated European sea bass juveniles after intramuscular injection 647 
with 106 TCID50 NNV per fish 30 days after intraperitoneal injection with PBS 648 
(Control) or UV-inactivated vaccine (iNNV). Curves show the mean mortality ± SEM 649 
(n = 2 replicates). Statistical analysis to determine differences between curves was 650 
performed by one-way ANOVA followed by Tukey’s post-hoc analysis. Different 651 
letters indicate significant differences (P<0.05) among groups. 652 
Figure 5: Challenge elicits both innate and specific humoral immunity in vaccinated 653 
sea bass. Bactericidal activity (A), anti-NNV activity (B) and specific anti-NNV IgM 654 
levels (C) in the serum of European sea bass specimens 2 days after intramuscular 655 
injection with 106 TCID50 NNV per fish [32 days after intraperitoneal vaccination with 656 
PBS (Control) or UV-inactivated vaccine (iNNV)]. Data represent the mean ± SEM (n 657 
= 6/group and time). Asterisks represent statistical differences between control and 658 
iNNV groups according to the t-Student test (P<0.05).  659 
Figure 6: iNNV vaccination produce little changes at transcriptional level upon 660 
challenge. Expression of immune-related genes in the brain (A) and head-kidney (B) of 661 
European sea bass specimens 2 days after intramuscular injection with 106 TCID50 662 
NNV per fish [32 days after intraperitoneal vaccination with PBS (Control) or UV-663 
inactivated vaccine (iNNV)]. Data represent the mean ± SEM (n = 6/group and time). 664 
Asterisks represent statistical differences between control and iNNV groups according 665 
to a t-Student test (P<0.05). ND, not detected. 666 
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Table 1: Gene accession numbers and primer sequences used for gene expression 668 
analysis. 669 
Immune function Name Gene Ac. number Sequence (5’3’) 
- Nodavirus capsid cp D38636 CGTGTCAGTCATGTGTCGCT 
CGAGTCAACACGGGTGAAGA 
Type I and II IFN 
pathway 
Type-I interferon ifn AM765847 GGCTCTACTGGATACGATGGC 
CTCCCATGATGCAGAGCTGTG 
IFN-induced GTP-binding protein mx 
AM228977, 
HQ237501, 
AY424961 
GAAGAAGGGCTACATGATCGTC 
CCGTCATTGTAGAGAGTGTGGA 
Signal transducer and activator of 
transcription 1 
stat1 DLAgn_00136580 
ACCGTCCGCTGTCTATTGACTA 
CAGATGCCCCAGCGAAACC 
Interferon-stimulated gene 15 isg15 HG916840 
CGACATCATCCGCACCTACA 
AGGCCTTGTCTTTGGGGATG 
Interferon gamma ifng KJ818329 
TCAAGATGCTGAGGCAACAC 
AGTGCTTTGCTCTGGACGAC 
Antigen 
presentation 
Major histocompatibility complex 1a mhc1a AM943118 
GGACAGACCTTCCCTCAGTG 
TCCAGATGAGTGTGGCTTTG 
Major histocompatibility complex 2b mhc2b AM113466 CAGAGACGGACAGGAAG 
CAAGATCAGACCCAGGA 
B cell markers 
and 
immunoglobulins 
Immunoglobulin mu heavy chain ighm FN908858 AGGACAGGACTGCTGCTGTT 
CACCTGCTGTCTGCTGTTGT 
Immunoglobulin tau heavy chain ight FM010886 TCACTTGGCAAATTGATGGA 
AGAACAGCGCACTTTGTTGA 
T cell markers 
T-cell receptor beta chain tcrb FN687461 GACGGACGAAGCTGCCCA 
TGGCAGCCTGTGTGATCTTCA 
Cluster of differentiation 8a cd8a AJ846849 CTGTCCTCCGCTCATACTGG 
TTGTAATGATGGGGGCATCT 
Cluster of differentiation 4 cd4 AM849812 ATTCTTTGCTAAGCCAGGCG 
CATTGTCTTGGTCTGGCGTC 
Cell-mediated 
cytotoxicity 
Perforin prf KY801204 CTGTACAACGGGCTTCTGGT 
ACTGGAGAACGTTGGACCAC 
Granzyme A gzma KJ818347 TCCCTGCTATGATGCAACTG 
ATTTCACCGTCTTGGTTTGC 
Housekeeping 
genes 
Elongation factor 1 alpha ef1a FM019753 CGTTGGCTTCAACATCAAGA 
GAAGTTGTCTGCTCCCTTGG 
Ribosomal protein L13 alpha l13a DT044539 GCGAAGGCATCAACATCTCC 
AGACGCACAATCTTGAGAGCAG 
 670 






